Edenbridge Pharmaceuticals is an emerging specialty pharmaceutical company focused on identifying, developing and marketing prescription pharmaceutical products.
Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable and accessible alternatives. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.
Founded in 2008, we launched our first product in February 2010 and currently sell our marketed products through every major channel of the U.S. prescription pharmaceutical market. In addition, we have a robust product development pipeline that includes ANDAs, 505(b)(2)s as well as foreign filings, and we have successfully developed and received FDA approval for several products.